| Pharmaceutical active ingredients: |
| Gemcitabine Hydrochloride |
| Available forms, composition and doses of Gemzar: |
| Injectable; Infusion; Gemcitabine Hydrochloride 200 mgInjectable; Infusion; Gemcitabine Hydrochloride 1 g |
| Gemzar medical category: |
| Human:Antineoplastic agentsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01BC05 - Gemcitabine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Eli LillyDiethelmDKSHFour StarY.C. WooZuellig Pharma |
| Related documents and information about Gemzar: |
| Gemzar prescribing information (PDF) |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Gemcite | Gemcitabine Hydrochloride | Eli Lilly |
| Gemcitera | Gemcitabine Hydrochloride | Tuteur Laboratorio; IMA Laboratorio |
| Gemcitover | Gemcitabine Hydrochloride | Lans-Pharm |
| Gemtabine | Gemcitabine Hydrochloride | Korea United Pharmaceutical; Qualimed Pharma |
| Gemtro | Gemcitabine Hydrochloride | Eli Lilly |
| Gemzitabin | Gemcitabine Hydrochloride | Teva |
| Gezt | Gemcitabine Hydrochloride | Richmond Laboratorios |
| Gitrabin | Gemcitabine Hydrochloride | Actavis; Apex Pharma Marketing; Firma Chun Cheong; Zuellig Pharma |
| Lifogem | Gemcitabine Hydrochloride | Samarth Pharma |
| Oncogem | Gemcitabine Hydrochloride | Cipla |